1. A Phase 2, Randomized, Double-blind, Placebo-Controlled Trial of Presatovir for the Treatment of Respiratory Syncytial Virus Upper Respiratory Tract Infection in Hematopoietic-Cell Transplant Recipients. (3rd December 2019) Authors: Chemaly, Roy F; Dadwal, Sanjeet S; Bergeron, Anne; Ljungman, Per; Kim, Yae-Jean; Cheng, Guang-Shing; Pipavath, Sudhakar N; Limaye, Ajit P; Blanchard, Elodie; Winston, Drew J; Stiff, Patrick J; Zuckerman, Tsila; Lachance, Silvy; Rahav, Galia; Small, Catherine B; Mullane, Kathleen M; Patron, Robert... Journal: Clinical infectious diseases Issue: Volume 71:Number 11(2020) Page Start: 2777 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗